Additionally, SIK2 phosphorylates MYLK at Ser343, and p-MYLK subsequently phosphorylates MLC2, thereby modulating cytoskeletal motility and promoting ovarian cancer invasion and metastasis [19]. Here, SIK2 is linked to ovarian carcinoma.